Blockade of ROCK inhibits migration of human primary keratinocytes and malignant epithelial skin cells by regulating actomyosin contractility.
Actin Cytoskeleton
/ metabolism
Actomyosin
/ metabolism
Cell Adhesion
/ physiology
Cell Line, Tumor
Cell Movement
/ physiology
Epidermis
/ metabolism
Epithelial Cells
/ metabolism
Focal Adhesions
/ metabolism
Humans
Keratinocytes
/ metabolism
Muscle Contraction
/ physiology
Myosin Light Chains
/ metabolism
Myosin-Light-Chain Kinase
/ metabolism
Myosin-Light-Chain Phosphatase
/ metabolism
Phosphorylation
Skin
/ metabolism
Stress Fibers
/ metabolism
rho-Associated Kinases
/ metabolism
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
27 12 2019
27 12 2019
Historique:
received:
21
08
2019
accepted:
11
12
2019
entrez:
29
12
2019
pubmed:
29
12
2019
medline:
4
11
2020
Statut:
epublish
Résumé
Actomyosin contractility, crucial for several physiological processes including migration, is controlled by the phosphorylation of myosin light chain (MLC). Rho-associated protein kinase (ROCK) and Myosin light chain kinase (MLCK) are predominant kinases that phosphorylate MLC. However, the distinct roles of these kinases in regulating actomyosin contractility and their subsequent impact on the migration of healthy and malignant skin cells is poorly understood. We observed that blockade of ROCK in healthy primary keratinocytes (HPKs) and epidermal carcinoma cell line (A-431 cells) resulted in loss of migration, contractility, focal adhesions, stress fibres, and changes in morphology due to reduction in phosphorylated MLC levels. In contrast, blockade of MLCK reduced migration, contractile dynamics, focal adhesions and phosphorylated MLC levels of HPKs alone and had no effect on A-431 cells due to the negligible MLCK expression. Using genetically modified A-431 cells expressing phosphomimetic mutant of p-MLC, we show that ROCK dependent phosphorylated MLC controls the migration, focal adhesion, stress fibre organization and the morphology of the cells. In conclusion, our data indicate that ROCK is the major kinase of MLC phosphorylation in both HPKs and A-431 cells, and regulates the contractility and migration of healthy as well as malignant skin epithelial cells.
Identifiants
pubmed: 31882703
doi: 10.1038/s41598-019-56447-2
pii: 10.1038/s41598-019-56447-2
pmc: PMC6934852
doi:
Substances chimiques
Myosin Light Chains
0
Actomyosin
9013-26-7
rho-Associated Kinases
EC 2.7.11.1
Myosin-Light-Chain Kinase
EC 2.7.11.18
Myosin-Light-Chain Phosphatase
EC 3.1.3.53
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
19930Références
Eur J Pharmacol. 2011 Jan 10;650(1):145-50
pubmed: 20959118
Physiol Rev. 2003 Oct;83(4):1325-58
pubmed: 14506307
Exp Cell Res. 2002 Aug 1;278(1):92-100
pubmed: 12126961
J Cell Biol. 2010 Nov 1;191(3):631-44
pubmed: 20974810
Cancer Res. 2009 Nov 15;69(22):8742-51
pubmed: 19887617
Biophys J. 2015 Sep 1;109(5):900-13
pubmed: 26331248
MethodsX. 2014 Jul 07;1:56-9
pubmed: 26150935
Proc Natl Acad Sci U S A. 2006 Jul 18;103(29):10889-94
pubmed: 16832052
Sci Rep. 2015 Mar 16;5:9167
pubmed: 25823914
Sci Rep. 2016 Apr 27;6:24925
pubmed: 27116935
FEBS Lett. 2006 Jul 24;580(17):4252-60
pubmed: 16828752
FEBS Lett. 1997 Mar 10;404(2-3):118-24
pubmed: 9119047
Invasion Metastasis. 1997;17(1):42-52
pubmed: 9425323
PLoS One. 2012;7(3):e33476
pubmed: 22479403
Nat Cell Biol. 2002 Apr;4(4):E97-100
pubmed: 11944043
PLoS One. 2015 Dec 16;10(12):e0144571
pubmed: 26673160
Cell Mol Bioeng. 2009 Jun;2(2):218-230
pubmed: 21297858
Front Pharmacol. 2017 May 23;8:292
pubmed: 28588494
Sci Rep. 2017 Mar 30;7:45624
pubmed: 28358024
Dis Model Mech. 2015 Dec;8(12):1495-515
pubmed: 26542704
Int J Cell Biol. 2012;2012:310616
pubmed: 22319531
Biomech Model Mechanobiol. 2016 Jun;15(3):511-23
pubmed: 26206449
Med Oncol. 2011 Jun;28(2):565-71
pubmed: 20300976
J Immunol. 2019 Apr 1;202(7):1949-1961
pubmed: 30760620
Prostate Cancer Prostatic Dis. 2003;6(3):212-6
pubmed: 12970723
PLoS One. 2015 May 21;10(5):e0126346
pubmed: 25996921
PLoS One. 2012;7(7):e40814
pubmed: 22808267
Science. 2003 Dec 5;302(5651):1704-9
pubmed: 14657486
J Invest Dermatol. 2008 Dec;128(12):2783-91
pubmed: 18548114
Biochem Soc Trans. 2011 Oct;39(5):1131-5
pubmed: 21936777
Oncotarget. 2017 Mar 28;8(13):21418-21428
pubmed: 28199964
Pancreas. 2002 Jan;24(1):34-41
pubmed: 11741180
Cancer Res. 1992 Nov 15;52(22):6400-3
pubmed: 1423288
PLoS One. 2014 Feb 11;9(2):e88489
pubmed: 24523903
J Neurobiol. 2000 Aug;44(2):97-113
pubmed: 10934315
Methods Mol Biol. 2013;931:313-29
pubmed: 23027009
PLoS One. 2013 Nov 04;8(11):e79776
pubmed: 24224004
J Invest Dermatol. 1998 Jan;110(1):72-5
pubmed: 9424091
BMC Cell Biol. 2011 Dec 02;12:52
pubmed: 22136066
Oncogene. 2012 Sep 27;31(39):4279-89
pubmed: 22249252
Hepatology. 2009 May;49(5):1583-94
pubmed: 19205033
Nat Cell Biol. 2010 Jun;12(6):598-604
pubmed: 20473295
Cell Motil Cytoskeleton. 2004 Jul;58(3):186-99
pubmed: 15146537
Biophys J. 2006 Nov 15;91(10):3907-20
pubmed: 16920834
Int J Dev Biol. 2011;55(7-9):835-40
pubmed: 22161839
Genes Cells. 2005 Feb;10(2):107-17
pubmed: 15676022